Literature DB >> 23785142

Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions.

Sabine Ruehle1, Floor Remmers, Hector Romo-Parra, Federico Massa, Melanie Wickert, Simone Wörtge, Martin Häring, Nadine Kaiser, Giovanni Marsicano, Hans-Christian Pape, Beat Lutz.   

Abstract

A major goal in current neuroscience is to understand the causal links connecting protein functions, neural activity, and behavior. The cannabinoid CB1 receptor is expressed in different neuronal subpopulations, and is engaged in fine-tuning excitatory and inhibitory neurotransmission. Studies using conditional knock-out mice revealed necessary roles of CB1 receptor expressed in dorsal telencephalic glutamatergic neurons in synaptic plasticity and behavior, but whether this expression is also sufficient for brain functions is still to be determined. We applied a genetic strategy to reconstitute full wild-type CB1 receptor functions exclusively in dorsal telencephalic glutamatergic neurons and investigated endocannabinoid-dependent synaptic processes and behavior. Using this approach, we partly restored the phenotype of global CB1 receptor deletion in anxiety-like behaviors and fully restored hippocampus-dependent neuroprotection from chemically induced epileptiform seizures. These features coincided with a rescued hippocampal depolarization-induced suppression of excitation (DSE), a CB1 receptor-dependent form of synaptic plasticity at glutamatergic neurons. By comparison, the rescue of the CB1 receptor on dorsal telencephalic glutamatergic neurons prolonged the time course of DSE in the amygdala, and impaired fear extinction in auditory fear conditioning. These data reveal that CB1 receptor in dorsal telencephalic glutamatergic neurons plays a sufficient role to control neuronal functions that are in large part hippocampus-dependent, while it is insufficient for proper amygdala functions, suggesting an unexpectedly complex circuit regulation by endocannabinoid signaling in the amygdala. Our data pave the way to a better understanding of neuronal networks in the context of behavior, by fine-tuned interference with synaptic transmission processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23785142      PMCID: PMC6618598          DOI: 10.1523/JNEUROSCI.4171-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

Review 1.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

2.  Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses.

Authors:  Stéphanie Trouche; Jennifer M Sasaki; Tiffany Tu; Leon G Reijmers
Journal:  Neuron       Date:  2013-10-31       Impact factor: 17.173

3.  The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors.

Authors:  Edgar Soria-Gomez; Carolina Muguruza; Bastien Redon; Giulia R Fois; Imane Hurel; Amandine Scocard; Claire Nguyen; Christopher Stevens; Marjorie Varilh; Astrid Cannich; Justine Daniault; Arnau Busquets-Garcia; Teresa Pelliccia; Stéphanie Caillé; François Georges; Giovanni Marsicano; Francis Chaouloff
Journal:  JCI Insight       Date:  2019-03-07

Review 4.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

5.  The endocannabinoid system controls food intake via olfactory processes.

Authors:  Edgar Soria-Gómez; Luigi Bellocchio; Leire Reguero; Gabriel Lepousez; Claire Martin; Mounir Bendahmane; Sabine Ruehle; Floor Remmers; Tifany Desprez; Isabelle Matias; Theresa Wiesner; Astrid Cannich; Antoine Nissant; Aya Wadleigh; Hans-Christian Pape; Anna Paola Chiarlone; Carmelo Quarta; Daniéle Verrier; Peggy Vincent; Federico Massa; Beat Lutz; Manuel Guzmán; Hirac Gurden; Guillaume Ferreira; Pierre-Marie Lledo; Pedro Grandes; Giovanni Marsicano
Journal:  Nat Neurosci       Date:  2014-02-09       Impact factor: 24.884

Review 6.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

7.  Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.

Authors:  J Megan Gray; Haley A Vecchiarelli; Maria Morena; Tiffany T Y Lee; Daniel J Hermanson; Alexander B Kim; Ryan J McLaughlin; Kowther I Hassan; Claudia Kühne; Carsten T Wotjak; Jan M Deussing; Sachin Patel; Matthew N Hill
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

8.  Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.

Authors:  Adán de Salas-Quiroga; Javier Díaz-Alonso; Daniel García-Rincón; Floortje Remmers; David Vega; María Gómez-Cañas; Beat Lutz; Manuel Guzmán; Ismael Galve-Roperh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

Review 9.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

10.  Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat.

Authors:  M D Lange; T Daldrup; F Remmers; H J Szkudlarek; J Lesting; S Guggenhuber; S Ruehle; K Jüngling; T Seidenbecher; B Lutz; H C Pape
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.